The Rest Of Europe Respiratory Care Devices Market was valued at $516.6 Million in 2025 and projected to reach to $752.9 Million by 2030, representing a compound annual growth rate of 7.8%. Rest Of Europe's respiratory care devices market is experiencing accelerated growth as healthcare systems modernize and invest in emergency medical capabilities.
Rest Of Europe's Respiratory Care Devices Market is valued at $516.6 million in 2025, demonstrating significant healthcare infrastructure investment across non-major European economies.
The region exhibits a robust 7.8% CAGR, outpacing the global average of 7.3%, indicating accelerated adoption of respiratory care technologies in emerging European healthcare systems.
Market size is projected to reach $752.9 million by 2030, representing a $236.3 million increase driven by aging populations and enhanced emergency medical infrastructure across Rest Of Europe.
Increasing government healthcare spending and EU regulatory harmonization are driving adoption of reusable resuscitators and advanced respiratory devices in hospitals and ambulatory care settings.
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | HOME CARE SETTINGS (End User) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 7.3% from 2025 to 2030 |
| Largest Segment | HOSPITALS (End User) |
| Market Size Base Year (Billions) | ~USD 23.62 (2025) |
| Revenue Forecast (Billions) | ~USD 33.6 (2030) |
| Segments Covered | Product, Type, Disease Indication, End User |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| ASTRAZENECA | United Kingdom | Public Company | Oncology,Cardiovascular, Renal and Metabolism (CVRM),Respiratory & Immunology, |
| KINDRED HEALTHCARE INC. | United States | Private Company | Injectable and infusion-based delivery (IV, subcutaneous, ports, pumps),Oral solid and liquid regimens (chronic disease management),Topical, transdermal, and local delivery, |
| DENTSPLY SIRONA | United States | Public Company | Connected Technology Solutions (imaging, CEREC, digital hardware),Essential Dental Solutions (endodontics, restorative, preventive consumables),Orthodontic and Implant Solutions (SureSmile, implants, digital dentures), |
| AMBU | Denmark | Public Company | Endoscopy (single-use and related systems),Airway Management and Anaesthesia,Neurology (EEG/EMG and IOM), |
| APTARGROUP INC | United States | Public Company | Pharma,Beauty,Closures, |
| CONMED CORPORATION | United States | Public Company | Orthopedic and sports medicine (BioBrace, TruShot, Y-Knot, Hall power tools),General surgery (AirSeal, Buffalo Filter, endomechanical, electrosurgery),Endoscopic technologies (GI therapeutics and diagnostics), |
| CONSORT MEDICAL | United Kingdom | Private Company | Inhalation devices (MDIs, DPIs, soft-mist),Injectable and autoinjector platforms,Nasal and other specialty delivery devices, |
| CONVATEC | United Kingdom | Public Company | Advanced wound care,Ostomy care,Continence and critical care, |
| HENRY SCHEIN | United States | Public Company | Global Distribution and Value-Added Services,Global Specialty Products,Global Technology, |
| ROSSMAX INTERNATIONAL LTD | Taiwan | Public Company | Blood pressure monitors & sphygmomanometers,Thermometers (including non-contact telephoto),Respiratory care (nebulizers, suction units, aero spacers, peak flow meters), |
| THE TIMKEN | United States | Public Company | Engineered Bearings,Industrial Motion, |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health, |
| MEDTRONIC | Ireland | Public Company | Cardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (including Diabetes), |
| RESMED INC. | United States | Public Company | Sleep and Breathing Health devices (PAP, ventilators, diagnostics),Cloud platforms and patient apps (AirView, myAir, connectivity modules),Residential Care Software (Brightree, HEALTHCAREfirst, MatrixCare, MEDIFOX DAN), |
| FISHER & PAYKEL HEALTHCARE LIMITED | New Zealand | Public Company | Hospital respiratory and humidification systems (adult and infant),Homecare OSA and chronic respiratory (CPAP devices, masks, humidifiers),Surgical and perioperative products, |
| DRäGERWERK AG & CO. KGAA | Germany | Public Company | Medical ventilators, anaesthesia, and lung monitoring,Patient monitoring, neonatal care, and hospital infrastructure,Gas detection (fixed and portable), |
| MASIMO | United States | Private Company | SET and Rainbow SET pulse oximetry and CO-oximetry,Brain function and hemodynamic monitoring, regional oximetry,Hospital automation and connectivity (Patient SafetyNet, Iris, iSirona, UniView, Replica), |
| GETINGE | Sweden | Public Company | Acute Care Therapies (ECMO, ventilation, monitoring, ICU infrastructure, drainage),Surgical Workflows (OR equipment, anesthesia, OR integration, sterile supply management),Life Science (biocontainment, sterilization, isolation, bioprocess, labware cleaning), |
| NIHON KOHDEN CORPORATION | Japan | Public Company | Patient monitors & clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, cath lab polygraphs),Defibrillators, AEDs, ventilators, anesthesia and therapeutic devices, |
| GE HEALTHCARE | United States | Public Company | Imaging,Advanced Visualization Solutions (including Ultrasound and Interventional),Patient Care Solutions, |
| ADAPTHEALTH, LLC | United States | Public Company | Sleep Health (PAP machines, supplies, OSA services),Respiratory Health (oxygen, ventilation, chronic therapy),Diabetes Health (CGMs, insulin pumps, supplies), |
| TELEFLEX INCORPORATED | United States | Public Company | Vascular access & emergency medicine (Arrow, EZ-IO, FAST1, QuikClot),Surgical products (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),Interventional cardiology and peripheral (GuideLiner, Turnpike, TrapLiner, MANTA, DCBs, stents), |
| AIR LIQUIDE | France | Public Company | Large Industries (oxygen, nitrogen, argon, hydrogen, CO, cogeneration),Industrial Merchant (packaged and bulk gases, equipment, hardgoods, services),Healthcare (medical gases, home healthcare, specialty ingredients, equipment), |
| ICU MEDICAL, INC. | United States | Public Company | Infusion therapy & IV solutions,Vascular access & needlefree connectors,Infusion pumps & medication safety software, |
AstraZeneca is a United Kingdom-based pharmaceutical company founded in 1992 that operates as a public company with 96,100 employees.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 with 64,200 employees.
Dentsply Sirona is a United States-based public company founded in 1877 with 14,000 employees, operating in the dental and oral healthcare sector.
Ambu is a Denmark-based public company founded in 1937 with 5,200 employees.
Aptar Group Inc. is a United States-based public company founded in 1992 with 14,000 employees.
ConMed Corporation is a United States-based public company founded in 1970 with 3,900 employees.
Consort Medical is a United Kingdom-based private company founded in 1938 with 2,000 employees.
ConvaTec is a United Kingdom-based public company founded in 1978.
Henry Schein is a United States-based public company founded in 1932 with 25,000 employees.
Rossmax International Ltd. is a Taiwan-based public company founded in 1988.
The Timken Company is a United States-based public company founded in 1899 with 19,000 employees.
Koninklijke Philips N.V. is a Netherlands-based public company founded in 1891 with 64,317 employees.
Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees.
ResMed Inc. is a United States-based public company founded in 1989 with 10,600 employees.
Fisher & Paykel Healthcare Limited is a New Zealand-based public company founded in 1934 with 7,396 employees.
Drägerwerk AG & Co. KGaA is a Germany-based public company founded in 1889 with 16,033 employees.
Masimo is a United States-based private company founded in 1989 with 2,200 employees.
Getinge is a Sweden-based public company founded in 1904 with 11,754 employees.
Nihon Kohden Corporation is a Japan-based public company founded in 1951 with 6,116 employees.
GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees.
AdaptHealth, LLC is a United States-based public company founded in 2012 with 10,900 employees.
Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees.
Air Liquide is a France-based public company founded in 1902 with 63,126 employees.
ICU Medical, Inc. is a United States-based public company founded in 1984 with 13,000 employees.
Reusable Resuscitators are valued at $516.6 million in 2025, representing a significant segment of the global Respiratory Care Devices Market.
Reusable Resuscitators are forecast to reach $752.9 million by 2030, reflecting a 7.8% compound annual growth rate over the forecast period.
Reusable Resuscitators are preferred due to their cost-effectiveness, durability, environmental sustainability, and proven reliability in emergency resuscitation protocols.
Growth in Reusable Resuscitators is driven by regulatory mandates for emergency preparedness, increased healthcare infrastructure investment, and the economic advantages of reusable over disposable devices.
Reusable Resuscitators are primarily used in hospitals, emergency departments, ambulances, pre-hospital care settings, and clinical training facilities worldwide.
This study involved four major activities in estimating the current respiratory care devices market size. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the respiratory care devices market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, as well as key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the respiratory care devices market. The primary sources from the demand side included industry experts, purchase & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
A breakdown of the primary respondents for the respiratory care devices market is provided below:
Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.
Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion.
Source: MarketsandMarkets Analysis
To know about the assumptions considered for the study, download the pdf brochure
For the global market value, annual revenues were calculated based on the revenue mapping of major product manufacturers and OEMs active in the global respiratory care devices market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global respiratory care devices market was split into various segments and subsegments based on:
The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

After arriving at the overall size of the global respiratory care devices market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.
Respiratory care is a healthcare specialty that provides diagnostic evaluation, management, control, therapy, and monitoring of cardiopulmonary system diseases and disorders. Respiratory care devices are extensively used in general & surgical wards and ICUs as a life support measure.
Full forecast, segment splits, and company analysis for all Respiratory Care Devices Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report